J&J's Mammotome
This article was originally published in The Gray Sheet
Executive Summary
Hand-held version of the minimally invasive breast biopsy device will be launched by Johnson & Johnson's Ethicon Endo-Surgery business this fall, following 510(k) clearance Sept. 1. The system will be priced comparably to the original Mammotome, which is mounted to an imaging table and has been available in the U.S. since 1995. The new version can perform biopsies more easily on a wider range of breast abnormalities, and allows for greater patient comfort, J&J claims